$155.11
▼ -3.0% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 24
▼ 1
Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff?
Overview
52-week range
$122
$170
69% of range
Avg surprise (last 2)
+4.6%
Avg reaction (last 2)
-1.3%
50% positive
Latest IV / EM
30%
EM ±4.7% · $160 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Jul 17, 2025 | Jun/2025 | $2.42 | $2.38 | +1.7% | — | -3.3% | earnings |
| Tue Apr 29, 2025 | Mar/2025 | $2.28 | $2.12 | +7.5% | — | +0.7% | earnings |